TAGAMET
- Product NDC
- 52183-223
- 11-digit product format
- 521830223
- Labeler code
- 52183
- Product ID
- 52183-223_e042ef55-48d2-43c6-91d1-55becd1f9f7c
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- cimetidine
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Prestige Brands Holdings, Inc.
- Application
- NDA020238
- Marketing category
- NDA
- Marketing start
- 2023-02-01
- Substance
- CIMETIDINE
- Active strength
- 200 mg/1
- Pharmacologic classes
- Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- TAGAMET
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| CIMETIDINE | 200 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 80061L1WGD |
| Rxcui | 104062, 197505 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 52183-223-30 | TAGAMET | 10 in 1 BLISTER PACK | TABLET | 10 | | 1 |
| 52183-223-30 | TAGAMET | 3 in 1 BOX | TABLET | 3 | | 1 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 52183-223 | TAGAMET (CIMETIDINE) TABLET [PRESTIGE BRANDS HOLDINGS, INC.] | 1 | Current NDC, 2 package rows | 20230201_c8ba8815-9d99-439f-b397-3869f729d9f4.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 52183-223-30 | 52183022330 | 3 BLISTER PACK in 1 BOX (52183-223-30) / 10 TABLET in 1 BLISTER PACK | 3 blister pack | 2023-02-01 | No | No | Current |